Showing results (1401-1410 of 1,437) with videos related to
Sort By:
Pageof 144
Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4+ CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.Haematologica|November 6, 2025
IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapyFieke W Hoff, Ying Huang, Rina Li Welkie, et al.Nature Medicine|May 2, 2018
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemiaJoseph A Fraietta, Simon F Lacey, Elena J Orlando, et al.Plos Medicine|December 21, 2006
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domainJeffrey C Lee, Igor Vivanco, Rameen Beroukhim, et al.Nature Medicine|January 24, 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapyGuido Ghilardi, Joseph A Fraietta, James N Gerson, et al.Nature Medicine|October 27, 2020
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master TrialAmy Burd, Ross L Levine, Amy S Ruppert, et al.Blood|December 29, 2022
DNA polymerase θ protects leukemia cells from metabolically induced DNA damageUmeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska, et al.Nature Medicine|July 21, 2015
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myelomaAaron P Rapoport, Edward A Stadtmauer, Gwendolyn K Binder-Scholl, et al.Blood|April 25, 2021
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALLElisabeth Paietta, Kathryn G Roberts, Victoria Wang, et al.The Journal of Clinical Investigation|August 16, 2021
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemiaWeimin Kong, Alexander Dimitri, Wenliang Wang, et al.Pageof 144